BioPharm International-10-01-2013

The pharmaceutical industry grows despite conflict in the Middle East.

Perspectives on Outsourcing

October 01, 2013

Practicality of implementation should be a part of vision in the bio/pharmaceutical industry.

A twin-column periodic countercurrent capture process that combines an efficient sequential, countercurrent loading process with a minimal twin-column hardware configuration is described.

Guest Editorial

October 01, 2013

Through its educational and networking opportunities, the American Association of Pharmaceutical Scientists plays an important role in partnering throughout the drug- development and commercialization process.

Regulatory Beat

October 01, 2013

Manufacturing standards are considered key to preventing drug recalls and shortages.

The authors review the angiopoietin pathway as an alternative for safer and more efficacious anti-angiogenic therapeutics.

Global Report

October 01, 2013

Foreign companies zero in on Myanmar with the hope of securing a foothold in its pharmaceutical market.

By embracing efficiency and quality, biopharmaceutical organizations can work better and achieve better work.

Early-stage companies are now embraced by buyers of new issues.

Analytical Best Practices

October 01, 2013

A well-designed comparability study can demonstrate the performance and advantages that can be gained when adopting a new protocol.

The correlation between limulus amebocyte lysate (LAL) assay and rabbit pyrogen test (RPT) targeting recombinant human epidermal growth factor (rhEGF) as active molecule was assessed.

Click the title above to open the BioPharm International October 2013 issue in an interactive PDF format.